A pharmacist conducting an MTM comprehensive medication review (CMR) identifies that a patient with type 2 diabetes has an A1C of 9.8% despite being on metformin 1000 mg twice daily. What is the most appropriate next step in the care planning process?
-
A
Document the finding and schedule a follow-up in 6 months
-
B
Identify a drug therapy problem related to the need for additional antidiabetic therapy
-
C
Immediately discontinue metformin and recommend insulin
-
D
Refer the patient to a dietitian without updating the medication action plan